Pharmaceutical is part of our work in Life Sciences.
People rely on the pharmaceutical industry for life-saving drugs and treatments, as well as those that improve the quality of life. Even with billions of dollars invested in research and development, few drugs make it through clinical trials and stringent regulatory clearances necessary to get to market. For those that do, it is crucial that the companies have protected the intellectual property (IP) underlying new drugs and treatments. Finnegan has a long history of working with innovative pharmaceutical companies to protect and maximize their valuable IP rights and assets, strategizing prosecution pathways and portfolio planning.
Our clients’ business and IP assets are global; protecting these assets across jurisdictions is increasingly challenging. With offices around the world and experience with multinational companies, Finnegan has the resources and experience to formulate and execute global strategies for pharmaceutical companies. The fast pace of new discoveries and their commercial applications require a comprehensive grasp of the IP legal issues and the industry insight to understand the scientific and strategic implications of the advancements.
With experience addressing virtually every type of IP issue for our pharmaceutical clients, we help by:
We work with clients innovating and advancing science in myriad fields, including:
1:20-cv-01226, D. Del., Judge Andrews
18-2232, Fed. Cir., Judges Newman, O'Malley, Taranto
IPR2017-00190, PTAB, Judges Mitchell, Franklin, Pollock
IPR2017-01429, PTAB, Judges Mitchell, Franklin, Pollock
3:18-cv-13635, D.N.J., Judges Martinotti, Goodman
2020-1747, -1748, -1749, -1750, -1751, -1752, -1876, -1877, -1878, Fed. Cir.
2:16-cv-09038, D.N.J., Judges Chesler, Waldor
1:18-cv-00664, D. Del., Judge Andrews
PGR2019-00043, PTAB, Judges Mitchell, Paulraj, Cotta
Webinar
Sanofi, Vanda, and GSK, a New Year Voyage through the Land of Induced Infringement
January 21, 2021
Webinar
Webinar
Inducement in a Pharmaceutical, Post-Launch Non-Hatch-Waxman World
December 17, 2020
Webinar
IP FDA Blog
FDA Final Guidance on Enhancing the Diversity of Clinical Trial Populations
November 19, 2020
Webinar
Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges
February 16, 2021
Webinar
Commentary
How I Made Partner: Finnegan's Danielle Duszczyszyn Shares Six Keys to Business Development Success
December 16, 2020
Press Release
Finnegan Celebrates Two Wins at the 2020 LMG Life Sciences Awards and Top Honors in the Rankings
October 5, 2020
Announcement
Margaret Esquenet Wins “Best in Copyright” at Women in Business Law Awards
September 22, 2020
Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.